Performance in the fourth quarter was pressured by a sharp decline in U.S. phosphate demand due to farmer affordability challenges and delayed government support.

Management successfully restored the operational foundation by achieving record mining production at Miski Mayo and the highest Florida rock production in three years.

Phosphate production improvements are driven by a strategic focus on P2O5 output, allowing the company to flex product grades to meet shifting market demand.

The Mosaic Biosciences platform doubled net sales to $68 million in 2025, leveraging global market access and high-margin biological products to diversify revenue.

Strategic divestitures of non-core assets like Carlsbad and Patos de Minas are intended to reduce asset retirement obligations and refocus capital on higher-return core operations.

Market positioning remains constructive as China's export restrictions and rising lithium iron phosphate battery demand tighten global phosphoric acid supply.

Operational efficiency gains included a $20 per tonne structural improvement in phosphate cash conversion costs and achieving a $150 million cost savings target ahead of schedule.

Management expects to produce at least 7 million tonnes of phosphate and approximately 9 million tonnes of potash in 2026, assuming normalized operating rates.

Guidance for 2026 includes an additional $100 million in technology-enabled cost savings through supply chain optimization and enhanced productivity initiatives.

Capital expenditures are projected to rise to $1.5 billion in 2026 due to essential gyp stack and clay settling area expansions, before trending down toward $1 billion by 2030.

Cash flow recovery is predicated on a projected $300 million to $500 million working capital release as excess inventory and rock stockpiles are drawn down.

Mosaic Biosciences is positioned to double net sales again in 2026, supported by 8 to 10 planned new product launches and expanded global registrations.

A significant spike in sulfur prices since December is expected to compress margins in Phosphate and Fertilizantes segments through the first half of 2026.

Management idled the Araxa and Fospar operations in Brazil as a defensive measure against margin compression and high raw material costs.

The company is pursuing strategic alternatives for selected Brazilian assets, including unlocking value from niobium and other critical mineral co-products.

Working capital builds in 2025 led to an $829 million increase in net debt, prompting a shift in capital allocation to prioritize debt reduction over extraordinary shareholder returns in the near term.

Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here.

Management noted that while international markets show a better ability to absorb price increases due to subsidies, U.S. pass-through may be limited by farmer affordability.

The company views a phosphate stripping margin above $300 as constructive, even if full cost pass-through is not achieved.

To reach an 8 million tonne annual rate, the company requires a low-80s operating factor across North American assets.

Current production guidance of 7 million tonnes is based on demonstrated trailing performance, but management sees upside as facilities exit scheduled turnarounds in the first half of 2026.

Mosaic is taking a prudent approach to Brazil distribution, refusing to take on excessive credit risk despite expanding planted acreage trends.

The company expects the Brazilian market to remain flat in 2026 as the industry undergoes consolidation following increased bankruptcy filings among retailers and growers.

Management indicated that the 14-15% drop in North American phosphate shipments mostly affected fall applications, meaning yield impacts would first be visible in the current crop year.

Precision agriculture and biological products are being used by farmers to mitigate lower application rates by improving nutrient use efficiency.

One stock. Nvidia-level potential. 30M+ investors trust Moby to find it first. Get the pick. Tap here.